How Turbine Accelerates Drug Discovery with AI Simulation | Szabi Nagy, CEO and Co-Founder of Turbine
About this episode
Szabi Nagy discusses his experiences and insights on drug discovery using AI at Turbine.
In this episode we are joined by Szabi Nagy, CEO and Co-Founder of Turbine. He shares his first startup experience, and how the lessons he learned there helped shape his work at Turbine. He then goes on to introduce the company’s virtual lab platform, which allows researchers to simulate experiments with AI and accelerate drug discovery. Throughout the discussion, Szabi provides honest insights into fundraising in today’s tight capital markets and offers valuable advice for biotech founders on how to stay resilient while navigating uncertainty and building impactful companies.
More episodes of Nucleate Podcast
- From Genomics to Deal-Making: How Science Becomes a Company | Laurence Reid, Biotech Entrepreneur
- Negotiating Intellectual Property, Staying Focused, and Making the Most of Mentors with Michal Preminger, Board Member at MassBio
- The Science of Stem Cells and Social Impact: Inside Ovelle with Merrick Smela and Travis Potter
- Inside TechBio Investing | Claire Smith, Partner at Springtide VC
- Functional Precision Oncology, a new compass for cancer care | Apricot Bio
- The Art and Science of Drug Hunting | Christoph Lengauer, CSO & Co-Founder of Curie.bio
Explore listener stats, chart rankings, contacts and more on the Nucleate Podcast podcast page.